The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …

The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the
early stages of disease. Patients with higher education levels may experience a marked …

Based on the recent literature and collective experience, an international consortium
developed revised guidelines for the diagnosis of behavioural variant frontotemporal …

This multicenter study examined 18F-FDG PET measures in the differential diagnosis of
Alzheimer's disease (AD), frontotemporal dementia (FTD), and dementia with Lewy bodies …

Frontotemporal dementia (FTD) and Alzheimer's disease are sometimes difficult to
differentiate clinically because of overlapping symptoms. Using diffusion tensor imaging …

Dementia is a leading cause of disability and death worldwide. At present there is no
disease modifying treatment for any of the most common types of dementia such as …

Background: The PET tracer 11C-labeled Pittsburgh Compound-B (11C-PIB) specifically
binds fibrillar amyloid-beta (Aβ) plaques and can be detected in Alzheimer disease (AD). We …

The differential diagnosis of neurodegenerative brain diseases on clinical grounds is
difficult, especially at an early disease stage. Several studies have found specific regional …

OBJECTIVE. We review the role of brain FDG PET in the diagnosis of Alzheimer disease,
frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic …

PET imaging with [F-18] FDG has been used extensively for research and clinical
applications in dementia. In the brain,[F-18] FDG accumulates around synapses and …